Zhenchong Xiong

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Endoplasmic Reticulum

Top Venues

British journal of cancer

Clinical and translational medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Zhenchong Xiong, Lin Yang, Chao Zhang, Weiling Huang, Wenjing Zhong, Jiarong Yi, Jikun Feng, Xiazi Zouxu, Libing Song, Xi Wang
MANF facilitates breast cancer cell survival under glucose-starvation conditions via prkn-mediated mitophagy regulation. Autophagy (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Correction: Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Correction: Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)
Jikun Feng, Jiarong Yi, Xiazi Zouxu, Jianxia Li, Zhenchong Xiong, Xinjian Huang, Wenjing Zhong, Weiling Huang, Feng Ye, Xi Wang
Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer. Cancer medicine 11 (15) (2022)
Zhenchong Xiong, Lin Yang, Guangzheng Deng, Xinjian Huang, Xing Li, Xinhua Xie, Jin Wang, Zeyu Shuang, Xi Wang
Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data. Journal of clinical medicine 7 (6) (2018)
Zhenchong Xiong, Liping Ye, Zhen Yu He, Fengyan Li, Yahui Xiong, Chuyong Lin, Xianqiu Wu, Guangzheng Deng, Wei Shi, Libing Song, Zhongyu Yuan, Xi Wang
ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1. Molecular oncology 12 (6) (2018)
Liping Ye, Fengyan Li, Yipeng Song, Donglin Yu, Zhenchong Xiong, Yue Li, Tianyi Shi, Zhongyu Yuan, Chuyong Lin, Xianqiu Wu, Liangliang Ren, Xinghua Li, Libing Song
Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer. International journal of cancer 143 (10) (2018)